Era7 Receives $430K Grant
News Jan 13, 2016
The ministry of Industry through their Agency CDTI has granted $1 M to the consortium CARDIOBIOME in which Era7 Bioinformatics has the task of developing a cloud based bioinformatics platform for the analysis of 16S data from human microbiomes and for facilitating the integration with EHR (Electronic Health Record) following standards like HL7, FHIR and SMART.
The Project will be focused on Acute Myocardial Infarction as proof of concept and more than 4000 samples from patients will be sequenced. “This new research and development project will be a new impulse for getting our goal: to be an international reference for 16S metagenomics, especially for microbiome projects” declared Dr. Eduardo Pareja, CEO of Era7. “The general interest in getting genomics data integrated with health care pipelines and EHR should be complemented with the integration of 16S metagenomics results since these results will be very important as useful biomarkers for prevention, diagnosis and follow-up of many diseases. In Era7, we are convinced that Precision Medicine will incorporate in the EHR 16S data from different microbiomes: oral, gut, blood, skin, bronchial or from disease-specific regions as tumors or abscesses.” Added Eduardo Pareja.
Microbiome analysis is an exponentially growing application of NGS not only for human health studies but also for sectors such as animal and plant health, industry, biofuel or agrifood.
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.